Cargando…
Donepezil may reduce the risk of comorbidities in patients with Alzheimer's disease: A large-scale matched case-control analysis in Japan
INTRODUCTION: Few studies have focused on the association between donepezil and physical comorbid conditions in Alzheimer's disease patients. METHODS: We investigated the association between donepezil prescription and the occurrences of comorbidities in Alzheimer's disease patients, by usi...
Autores principales: | Kobayashi, Hiroyuki, Arai, Heii |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6021551/ https://www.ncbi.nlm.nih.gov/pubmed/29955656 http://dx.doi.org/10.1016/j.trci.2018.03.002 |
Ejemplares similares
-
Unmasking the benefits of donepezil via psychometrically precise identification of mild cognitive impairment: A secondary analysis of the ADCS vitamin E and donepezil in MCI study
por: Edmonds, Emily C., et al.
Publicado: (2017) -
No synergistic effect of subtherapeutic doses of donepezil and EVP-6124 in healthy elderly subjects in a scopolamine challenge model
por: Baakman, Anne Catrien, et al.
Publicado: (2019) -
Large‐scale plasma proteomic profiling identifies a high‐performance biomarker panel for Alzheimer's disease screening and staging
por: Jiang, Yuanbing, et al.
Publicado: (2021) -
Transdermal donepezil on the treatment of Alzheimer’s disease
por: Sozio, Piera, et al.
Publicado: (2012) -
Reducing Risks and Improving Vascular Access Outcomes
por: Morrell, Elizabeth
Publicado: (2020)